- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Bellerophon Therapeutics (NASDAQ:BLPH), Quotes and News Summary
Bellerophon Therapeutics (NASDAQ: BLPH)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-23 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.540 | -0.590 | -0.0500 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Bellerophon Therapeutics Questions & Answers
You can purchase shares of Bellerophon Therapeutics (NASDAQ: BLPH) through any online brokerage.
Other companies in Bellerophon Therapeutics’s space includes: Allena Pharma (NASDAQ:ALNA), Addex Therapeutics (NASDAQ:ADXN), Midatech Pharma (NASDAQ:MTP), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and BioRestorative Therapies (NASDAQ:BRTX).
The latest price target for Bellerophon Therapeutics (NASDAQ: BLPH) was reported by Jefferies on Tuesday, August 11, 2020. The analyst firm set a price target for 19.00 expecting BLPH to rise to within 12 months (a possible 1361.54% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Bellerophon Therapeutics (NASDAQ: BLPH) is $1.3 last updated Today at August 10, 2022, 4:12 PM UTC.
There are no upcoming dividends for Bellerophon Therapeutics.
Bellerophon Therapeutics’s Q2 earnings are confirmed for Tuesday, August 23, 2022.
There is no upcoming split for Bellerophon Therapeutics.
Bellerophon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.